Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000804065 | SCV000943959 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2022-07-24 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 577 of the SDCCAG8 protein (p.Gln577Pro). This variant is present in population databases (rs771493123, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SDCCAG8-related conditions. ClinVar contains an entry for this variant (Variation ID: 649190). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000804065 | SCV002784696 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2022-05-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004538099 | SCV004120128 | uncertain significance | SDCCAG8-related disorder | 2024-02-13 | criteria provided, single submitter | clinical testing | The SDCCAG8 c.1730A>C variant is predicted to result in the amino acid substitution p.Gln577Pro. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.032% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |